Ultragenyx Pharmaceutical
RARE
RARE
307 hedge funds and large institutions have $3.42B invested in Ultragenyx Pharmaceutical in 2025 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 116 increasing their positions, 108 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
3% more funds holding
Funds holding: 297 → 307 (+10)
7% more repeat investments, than reductions
Existing positions increased: 116 | Existing positions reduced: 108
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Holders
307
Holding in Top 10
6
Calls
$149M
Puts
$87.7M
Top Buyers
| 1 | +$107M | |
| 2 | +$80.8M | |
| 3 | +$43.5M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$34.5M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$32.7M |
Top Sellers
| 1 | -$22.5M | |
| 2 | -$21M | |
| 3 | -$18.2M | |
| 4 |
VPC
Vestal Point Capital
New York
|
-$18.1M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$17.8M |
